Haemophilus parainfluenzae is an unusual cause of invasive bacterial disease and is particularly uncommon as a reported etiology of neonatal sepsis in current large published series. We describe a seriously ill, very low birth weight (VLBW) infant with documented early onset sepsis caused by H. parainfluenzae. We compare our case with those published previously and contrast the clinical presentation of infection in our patient to that of common bacterial pathogens causing neonatal sepsis. Our review suggests many common factors in the pathogenesis of early onset infection by H. parainfluenzae.
Haemophilus parainfluenzae is an unusual cause of invasive bacterial disease and is particularly uncommon as a reported etiology of neonatal sepsis in current large published series. We describe a seriously ill, very low birth weight (VLBW) infant with documented early onset sepsis caused by H. parainfluenzae. We compare our case with those published previously and contrast the clinical presentation of infection in our patient to that of common bacterial pathogens causing neonatal sepsis. Our review suggests many common factors in the pathogenesis of early onset infection by H. parainfluenzae.
Haemophilus species other than Haemophilus influenzae have been considered to be rare causes of human disease. H. parainfluenzae, H. aphrophilus, H. paraphrophilus, H. aegyptius, and H. ducreyi are among the species implicated.
Haemophilus species are considered to be normal flora in both the upper respiratory tract (oral cavity and pharynx) and the urogenital tract. 1, 2 Clinical infection due to Haemophilus species may occur as a result of local or blood stream invasion from sites of colonization or may occur due to growth of organisms in an abnormal fluid collection, leading to systemic symptoms. However, the incidence of infections caused by species other than H. influenzae (both typable and nontypable strains) is felt to be low. H. parainfluenzae has been documented to cause substantial pathology, including endocarditis, pharyngitis, otitis media, meningitis, brain abscesses, epiglottitis, pneumonia, conjunctivitis, dental abscesses, empyema, septicemia, septic arthritis, osteomyelitis, peritonitis, hepatobiliary infections, epidural abscesses, and urinary tract and genital (prostatic, urethral) infections. [3] [4] [5] [6] [7] The majority of these infections have only been reported in adults. Pediatric infections have included diseases of the upper and lower respiratory tract, endocarditis, meningitis, and brain abscesses in infants with long standing respiratory infections. 4, 6, 8 Documented cases of neonatal sepsis due to H. parainfluenzae are still very rare. 9, 10 We present a case of overwhelming H. parainfluenzae sepsis in a very low birth weight (VLBW) premature infant, and a review of the medical literature.
CASE REPORT
A female infant born at 27 weeks gestation to a 33-year-old gravida 6 para 4,1,1 mother was transferred at 10 hours of age to Children's Hospital San Diego with evidence of sepsis, respiratory distress, and pulmonary hypertension. The mother's routine prenatal evaluation was unremarkable. The mother had ruptured membranes for 8 days before the delivery but remained afebrile and did not receive any antibiotics. The infant was delivered via cesarean section secondary to active labor with breech presentation. Apgar scores were 8 and 8 at 1 and 5 minutes, respectively, with a birth weight of 900 gm. The infant began having unstable vital signs within the first hour of life and was subsequently intubated. An initial analysis of arterial blood gases showed a PCO 2 of 52 mm Hg, a pH of 7.19, a PO 2 of 51 mm Hg, and a base excess of Ϫ8.0 meq/liter. The baby needed increasing mechanical ventilation; with worsening respiratory failure, she required highfrequency oscillatory ventilation. Dexamethasone (0.5 mg/kg per dose) and inotropic support with dopamine, dobutamine, and milrinone were also begun. Blood, tracheal, and urine cultures for bacteria were obtained. The infant received empirical antibiotic therapy with ampicillin and cefotaxime. An initial complete blood count showed neutropenia with an absolute neutrophil count of 480/mm 3 and a total white blood cell count of 6000/mm 3 with a differential that included only 6% segmented neutrophils and 2% band forms. She developed progressive neutropenia, with a total white blood cell count of 800/mm 3 (10% segmented neutrophils and 2% band forms) at 3 hours of life. The platelet count was 217,000/mm 3 at this time. A urine bacterial antigen screen was negative for group B streptococcus. The infant's laboratory evaluation demonstrated mild disseminated intravascular coagulation, with a prothrombin time of 18.7 seconds, a partial thromboplastin time of 80 seconds, and a fibrinogen of 1.54 gm/liter (154 mg/dl), but with undetectable D-dimers. Consequently, cryoprecipitate was given. Antibiotic therapy was changed to cefotaxime (50 mg/kg per dose), vancomycin (5 mg/kg per dose), and gentamicin (3 mg/kg per dose) based on the infant's deterioration. She also received an infusion of intravenous immune globulin at a dose of 300 mg/kg. Given her documented leukopenia, she was treated with granulocyte colony-stimulating factor as well.
The infant's blood culture and initial cultures of tracheal secretions yielded H. parainfluenzae (␤-lactamase-negative) by day 3 of
life. Vancomycin and gentamicin were discontinued. Cefotaxime alone was continued for a total of 10 days of therapy. At no point during the infant's hospital course did her physical examination or clinical presentation suggest infective endocarditis. It was noted upon histologic evaluation of the placenta that the mother had chorioamnionitis. No maternal bacterial cultures had been obtained.
The infant was extubated without difficulty on day 24 of life but was noted to have bilateral grade II intraventricular hemorrhages and a patent ductus arteriosus. She was discharged from the hospital after 2 months of hospitalization.
DISCUSSION
The suspicion of early onset sepsis at the time of delivery is almost universal in VLBW preterm infants (401 to 1000 gm). The initiation of antibiotic therapy at birth is common practice. 11 Although the overall incidence of neonatal sepsis has changed very little, there has been a marked decrease in documented early onset sepsis, possibly attributable to the increased use of prenatal antibiotics. 12 Mortality ranges from 30% to 70% among those infants who have early onset septicemia and is inversely related to the birth weight. [12] [13] [14] [15] Risk factors for neonatal sepsis include an Apgar score of Ͻ6 at 5 minutes, prolonged rupture of membranes, placental inflammation, and clinical amnionitis (maternal fever, fetal tachycardia, and amniotic or gastric fluid leukocytes or bacteria). 15 Decreased gestational age and male sex have also been associated with an increased incidence of early neonatal sepsis. [11] [12] [13] Some of these same risk factors have been related to an increased incidence of neonatal sepsis with H. influenzae. 16, 17 In a study of early onset sepsis in VLBW neonates by Stoll et al., group B streptococcus caused 31% of the infections, followed by Escherichia coli (16%), and H. influenzae (12%).
11 H. parainfluenzae was not found to be a pathogen in this review. No distinct risk factors appear to be related to H. parainfluenzae sepsis, although our patient represents only the fifth reported case.
The clinical features of early onset sepsis in babies of Ͻ34 weeks gestation are often indistinguishable from those of birth asphyxia or respiratory distress syndrome. More mature infants may present within 24 hours of birth with episodes of respiratory distress, apnea and bradycardia, or more specific signs of sepsis including hypotension, metabolic acidosis, disseminated intravascular coagulation, and neutropenia. 11, 13, 14 The gold standard for documentation of bacterial sepsis is the blood culture. However, blood cultures in infants who appear to have bacterial sepsis may often be negative. In the study by Stoll et al., only 1.9% of blood cultures were positive in infants with clinically diagnosed sepsis, which underscores the difficulty of documenting a bacterial etiology of sepsis in the symptomatic immature neonate. 11 This is particularly challenging in cases in which intrapartum maternal antibiotic therapy has been administered, which may affect the ability to detect organisms in the neonatal blood cultures.
Serious infections due to H. parainfluenzae out of the neonatal period have also been reported since the first case of meningitis described in 1966, 18 including documented cases of respiratory infections, conjunctivitis, brain abscesses, osteomyelitis, skin abscesses, and hepatic abscesses. 6 A review of the literature documents meningitis and subacute infective endocarditis as the most frequently reported infections in children. 6 The overall mortality rate is 11%, and the combined rates of morbidity and mortality total 38%; a majority of infections (75%) in children occur between the ages of 6 months and 4 years.
Neonatal septicemia secondary to H. parainfluenzae infection is still very rare. Hable et al. suggested that neonatal infections may be rare secondary to the presence of protective maternal antibodies. 19 There have only been five previously reported cases. 9, 10 Only one case occurred in a premature infant, born at 27 weeks of gestation. Maternal infection was evident in two of the cases, with cultures indicative of puerperal sepsis and chorioamnionitis. A common factor was the presence of maternal membrane rupture for Ͼ8 hours before the delivery of the infant. In addition, four cases of neonatal sepsis were early in onset. This early onset may have been secondary to ascending infection from ruptured membranes, as H. parainfluenzae has been cultured from the genital tract of asymptomatic women. 2 Our infant had several risk factors for early neonatal sepsis given her low birth weight, her prematurity, her mother's markedly prolonged rupture of membranes, and her subsequent histologic evidence of chorioamnionitis. Therapy of infections caused by H. parainfluenzae should be based on susceptibility testing, as ␤-lactamase production in this organism occurs with a frequency that may be greater than seen with H. influenzae. 20 For ␤-lactamase-negative strains, ampicillin should represent appropriate therapy; for ␤-lactamase-positive strains, thirdgeneration cephalosporins such as cefotaxime should provide excellent antimicrobial activity. Aminoglycosides such as gentamicin demonstrate acceptable in vitro activity against Hemophilus sp but have not been evaluated as therapy for infections caused by these organisms.
This case and others reviewed in the literature support the significance of H. parainfluenzae as a neonatal pathogen. We believe that H. parainfluenzae should be considered in all cases of presumed early onset neonatal sepsis. Prolonged rupture of membranes, chorioamnionitis, and prematurity appear to be significant risk factors for this infection, as they are for the other bacterial pathogens causing early onset neonatal sepsis. However, despite optimal antibiotic therapy, sequelae may occur in these infants.
